These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19097556)

  • 1. RSV disease in the pediatric population: epidemiology, seasonal variability, and long-term outcomes.
    Simões EA
    Manag Care; 2008 Nov; 17(11 Suppl 12):3-6, discussion 18-9. PubMed ID: 19097556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
    Simoes EA; Carbonell-Estrany X
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season.
    Singleton RJ; Bruden D; Bulkow LR; Varney G; Butler JC
    Pediatr Infect Dis J; 2006 Dec; 25(12):1116-22. PubMed ID: 17133156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substantial variability in community respiratory syncytial virus season timing.
    Mullins JA; Lamonte AC; Bresee JS; Anderson LJ
    Pediatr Infect Dis J; 2003 Oct; 22(10):857-62. PubMed ID: 14551484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In the trenches: a pediatrician's perspective on prevention and treatment strategies for RSV disease.
    Frogel MP
    Manag Care; 2008 Nov; 17(11 Suppl 12):7-12, discussion 18-9. PubMed ID: 19097557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33-35 completed weeks' gestational age in Canada.
    Paes B; Steele S; Janes M; Pinelli J
    Curr Med Res Opin; 2009 Jul; 25(7):1585-91. PubMed ID: 19469698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of respiratory syncytial virus surveillance data to optimize the timing of immunoprophylaxis.
    Panozzo CA; Stockman LJ; Curns AT; Anderson LJ
    Pediatrics; 2010 Jul; 126(1):e116-23. PubMed ID: 20547651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond randomized controlled trials: a "real life" experience of respiratory syncytial virus infection prevention in infancy with and without palivizumab.
    Mitchell I; Tough S; Gillis L; Majaesic C
    Pediatr Pulmonol; 2006 Dec; 41(12):1167-74. PubMed ID: 17058279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of RSV: implications for managed care.
    Makari D; Hoopes JM; White N
    Manag Care; 2009 Jan; 18(1 Suppl 2):2-7. PubMed ID: 19230529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The causal direction in the association between respiratory syncytial virus hospitalization and asthma.
    Stensballe LG; Simonsen JB; Thomsen SF; Larsen AM; Lysdal SH; Aaby P; Kyvik KO; Skytthe A; Backer V; Bisgaard H
    J Allergy Clin Immunol; 2009 Jan; 123(1):131-137.e1. PubMed ID: 19130934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief report: respiratory syncytial virus activity--United States, July 2006-November 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Dec; 56(48):1263-5. PubMed ID: 18059258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory syncytial virus activity-- United States, July 2007-December 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Dec; 57(50):1355-8. PubMed ID: 19092759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks.
    Figueras-Aloy J; Carbonell-Estrany X; Quero-Jiménez J; Fernández-Colomer B; Guzmán-Cabañas J; Echaniz-Urcelay I; Doménech-Martínez E;
    Pediatr Infect Dis J; 2008 Sep; 27(9):788-93. PubMed ID: 18664927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between respiratory syncytial virus (RSV) test data and hospitalization of children for RSV lower respiratory tract illness in Florida.
    Light M; Bauman J; Mavunda K; Malinoski F; Eggleston M
    Pediatr Infect Dis J; 2008 Jun; 27(6):512-8. PubMed ID: 18449062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing.
    Simoes EA; Groothuis JR; Carbonell-Estrany X; Rieger CH; Mitchell I; Fredrick LM; Kimpen JL;
    J Pediatr; 2007 Jul; 151(1):34-42, 42.e1. PubMed ID: 17586188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory syncytial virus infection and immunoprophylaxis for selected high-risk children in Central Australia.
    Bolisetty S; Wheaton G; Chang AB
    Aust J Rural Health; 2005 Oct; 13(5):265-70. PubMed ID: 16171499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of hospitalization due to respiratory syncytial virus: results from the Palivizumab Outcomes Registry.
    Frogel M; Nerwen C; Cohen A; VanVeldhuisen P; Harrington M; Boron M;
    J Perinatol; 2008 Jul; 28(7):511-7. PubMed ID: 18368063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in timing of respiratory syncytial virus outbreaks: lessons from national surveillance.
    Panozzo CA; Fowlkes AL; Anderson LJ
    Pediatr Infect Dis J; 2007 Nov; 26(11 Suppl):S41-5. PubMed ID: 18090199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of altitude on hospitalizations for respiratory syncytial virus infection.
    Choudhuri JA; Ogden LG; Ruttenber AJ; Thomas DS; Todd JK; Simoes EA
    Pediatrics; 2006 Feb; 117(2):349-56. PubMed ID: 16452353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory syncytial virus activity - United States, July 2008-December 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(8):230-3. PubMed ID: 20203556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.